Literature DB >> 20605879

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

D J Birmingham1, F Irshaid, H N Nagaraja, X Zou, B P Tsao, H Wu, C Y Yu, L A Hebert, B H Rovin.   

Abstract

To assess the relationship between serum C3 or C4 levels and lupus renal flare, C3 and C4 levels were measured bimonthly in 71 lupus nephritis patients for a mean of 35 months, during which time 70 renal flares were identified. Comparing baseline, pre-flare, and at-flare values indicated that neither C3 nor C4 levels decreased pre-flare, but both decreased on average significantly at flare. However, sensitivity/specificity for C3 (75%/71%) and C4 (48%/71%) were low. To account for other influencing factors, multiple regression was performed that included bimonthly values of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), and genotype data on C3 (S/F), CRP (1846G > A), and the complement regulator factor H (Y402H). This analysis revealed that reduced levels of C4, but not C3, were independently associated with the two-month pre-flare period. Conversely, reduced levels of C3, but not C4, were independently associated with the flare visit. Significant pro-flare interactions included low C3 levels with the factor H 402HH-encoding genotype, and low CRP levels with the C3 F allele. Together these data suggest that C4 activation is critical for initiating renal flare while C3 activation is involved in the actual tissue damage, and that these effects are influenced by genetic variability in complement activation and regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605879      PMCID: PMC3086056          DOI: 10.1177/0961203310371154

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  45 in total

Review 1.  Exploring complement activation to develop biomarkers for systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  Arthritis Rheum       Date:  2004-11

2.  Genetic polymorphism of C3 and Bf in IgA nephropathy.

Authors:  M Rambausek; A W van den Wall Bake; R Schumacher-Ach; R Spitzenberg; U Rother; L A van Es; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1987       Impact factor: 5.992

3.  Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?

Authors:  J M Esdaile; L Joseph; M Abrahamowicz; Y Li; D Danoff; A E Clarke
Journal:  J Rheumatol       Date:  1996-11       Impact factor: 4.666

4.  Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.

Authors:  H Jarva; T S Jokiranta; J Hellwage; P F Zipfel; S Meri
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Authors:  Brad H Rovin; Huijuan Song; Dan J Birmingham; Lee A Hebert; Chack Yung Yu; Haikady N Nagaraja
Journal:  J Am Soc Nephrol       Date:  2004-12-15       Impact factor: 10.121

7.  "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

Authors:  G Moroni; S Quaglini; M Maccario; G Banfi; C Ponticelli
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

8.  Studies of serum C-reactive protein in systemic lupus erythematosus.

Authors:  Ralph C Williams; Molly E Harmon; Rufus Burlingame; Terry W Du Clos
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

9.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail.

Authors:  J M Esdaile; M Abrahamowicz; L Joseph; T MacKenzie; Y Li; D Danoff
Journal:  Arthritis Rheum       Date:  1996-03

10.  Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group.

Authors:  D M Ricker; L A Hebert; R Rohde; D D Sedmak; E J Lewis; J D Clough
Journal:  Am J Kidney Dis       Date:  1991-12       Impact factor: 8.860

View more
  53 in total

1.  Lupus: an overview of the disease and management options.

Authors:  William Maidhof; Olga Hilas
Journal:  P T       Date:  2012-04

Review 2.  Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.

Authors:  Daniel J Birmingham; Michael Merchant; Sushrut S Waikar; Haikady Nagaraja; Jon B Klein; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

3.  Outcome and predictors of kidney disease progression in Puerto Ricans with systemic lupus erythematosus initially presenting with mild renal involvement.

Authors:  Mariely Nieves-Plaza; Ana P Ortiz; Marilú Colón; María J Molina; Lesliane E Castro-Santana; Vanessa E Rodríguez; Angel M Mayor; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2011-06       Impact factor: 3.517

Review 4.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

5.  The clinical characteristics of low C4 alone in patients with systemic lupus erythematosus.

Authors:  Weiji Xie; Zeen Xiao; Jing Xu; Guitian Hong; Xiaochang Xu; Yimin Zhang; Xialan Zhang
Journal:  Clin Rheumatol       Date:  2020-08-27       Impact factor: 2.980

6.  Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.

Authors:  Amanda Mener; Seema R Patel; Connie M Arthur; Satheesh Chonat; Andreas Wieland; Manjula Santhanakrishnan; Jingchun Liu; Cheryl L Maier; Ryan P Jajosky; Kathryn Girard-Pierce; Ashley Bennett; Patricia E Zerra; Nicole H Smith; Jeanne E Hendrickson; Sean R Stowell
Journal:  JCI Insight       Date:  2018-11-15

7.  Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis.

Authors:  Stephen W Olson; Jessica J Lee; Lisa K Prince; Thomas P Baker; Patricia Papadopoulos; Jess Edison; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

8.  Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis.

Authors:  Cristiane B Dias; Patrícia Malafronte; Jin Lee; Aline Resende; Lectícia Jorge; Cilene C Pinheiro; Denise Malheiros; Viktoria Woronik
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

Review 9.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Authors:  Chandra Mohan; Shervin Assassi
Journal:  BMJ       Date:  2015-11-26

10.  Distribution of human leukocyte antigen alleles in systemic lupus erythematosus patients with angiotensin converting enzyme insertion/deletion polymorphism.

Authors:  Nageen Hussain; Ghazala Jaffery
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.